TVTX
USDTravere Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$32.600
High
$34.605
Low
$32.310
Volume
0.26M
Company Fundamentals
Market Cap
3.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.25M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Travere Therapeutics to Participate at Upcoming Investor Conferences
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.
Travere Therapeutics to Report Third Quarter 2025 Financial Results
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a
Related Stocks
FPF
First Trust Intermediate Duration Preferred & Income Fund Common Shares of Beneficial Interest
INNV
InnovAge Holding Corp.
PVL
Permianville Royalty Trust Trust Units
ABVEW
Above Food Ingredients Inc. Warrants
NGNE
Neurogene Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.